Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA(2)DS(2)-VASc scores

ST段抬高型心肌梗死并发新发房颤的风险评估:GRACE评分与CHA₂DS₂-VASc评分的比较

阅读:1

Abstract

PURPOSE: New-onset atrial fibrillation (NOAF) is a common finding in patients with myocardial infarction (MI), but few studies are available regarding the prediction model for its risk estimation. Although Global Registry of Acute Coronary Events (GRACE) risk score (RS) has been recognized as an effective tool for the risk evaluation of clinical outcomes in patients with MI, its usefulness in the prediction of post-MI NOAF remains unclear. In this study, we sought to validate the discrimination performance of GRACE RS in the prediction of post-MI NOAF and to make a comparison with that of the CHA(2)DS(2)-VASc score in patients with ST-segment elevation myocardial infarction (STEMI). PATIENTS AND METHODS: A total of 488 patients with STEMI who were admitted to our hospital between May 2015 and October 2016 without a history of atrial fibrillation were retrospectively evaluated in this study. GRACE and CHA(2)DS(2)-VASc scores were calculated for each patient. Patients were divided into low (GRACE RS≤125)-, intermediate (GRACE RS 126-154)-, and high (GRACE RS≥155)-risk groups. Receiver operating characteristic curve analyses were performed to evaluate the discrimination performance of both RSs. Model calibration was evaluated by using Hosmer-Lemeshow goodness-of-fit test (HLS). RESULTS: Of the 488 eligible patients, 49 (10.0%) developed NOAF during hospitalization. In the overall cohort, the discrimination performance of GRACE RS (C-statistic: 0.76, 95% CI: 0.72-0.80) was significantly better than that of CHA(2)DS(2)-VASc score (C-statistic: 0.68, 95% CI: 0.64-0.72; comparison p=0.03). For subgroup analysis, GRACE RS tended to be better than the CHA(2)DS(2)-VASc score in all but the intermediate-risk group as evidenced by C-statistics of 0.60 and 0.65 for GRACE and CHA(2)DS(2)-VASc scores, respectively. Excellent calibration was achieved except for GRACE RS in females (HLS p=0.05). CONCLUSION: The diagnostic performance of GRACE RS is relatively high as well as better than that of the CHA(2)DS(2)-VASc score with respect to the prediction of post-MI NOAF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。